Key subjects of the IMAC 2024 Congress:

• Nanostructuring of the T-cell receptor organization and signaling for immunotherapy;
• Individual approach to the treatment of severe bronchial asthma based on phenotypes. What is important for patients and physicians?
• Mechanisms of virus-induced recrudescences of allergic bronchial asthma;
• Allergens in domestic animals and their extracts, value for diagnosis and treatment;
• Screening technologies for the development of new immunotherapy-based drugs;
• Allergen molecules as biomarkers for diagnosis, treatment, and prognosis for the allergy to pollen and domestic animals;
• Genetic restriction of antigen presentation determines allergic sensitization and disease symptoms;
• From scientific evidence to clinical practice. Success story;
• Clinical experience of immunotherapy with recombinant allergens;
• Evolution of combined bronchodilators. How to improve performance for a patient?
• ASIT: Quo vadis? (Where we go?)
• Immunobiological therapy for immune-mediated skin diseases. Conversation of allergic immunologist and dermatologist.
• Flow cytometry: modern opportunities for a clinician.
• Biological therapy - from molecular mechanisms to clinical practice.
• Molecular mechanisms of antihistamines clinical efficacy;
• COVID-19 and vaccination